#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer Acute leukaemia Oesophageal carcinoma Hereditary angioedema Familial haemophagocytic lymphohistiocytosis Isodicentric chromosome 15 syndrome Plasma cell myeloma refractory Rectal cancer Fibrosarcoma metastatic Immune-mediated myasthenia gravis Basal cell naevus syndrome Congenital hypotransferrinaemia Rhabdoid tumour Encephalopathy neonatal Microvillous inclusion disease More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Trials in Disease Thrombotic thrombocytopenic purpura – Trials in Disease Atypical haemolytic uraemic syndrome – Life with Disease Lennox-Gastaut syndrome – Treatment Phenylketonuria Glycogen storage disease type II – Basic Information Kearns-Sayre syndrome – Life with Disease Vascular malformation Angiosarcoma metastatic Hairy cell leukaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    HUMAN THROMBIN Nebivolol Hydrochloride POLYMYXIN B SULFATE Cefuroxime ARFOLITIXORIN Germanium (68Ge) Chloride Dog Epithelium Extract Aaa802 Calcium Oxybate H2-Receptor Antagonist Lbl-007 Calcium Pantothenate Bp Eftilagimod Alfa Antithymocyte Immunoglobulin Seladelpar ADX-038 Entinostat Litifilimab Rilvegostomig Vortioxetine Hydrobromide More therapies…

    Learn about Your Condition

    Infant sedation Cardiac failure Mesothelioma Malignant melanoma stage IV Eye inflammation Nephrotic syndrome Renal cell carcinoma Gastrooesophageal cancer Pulmonary sarcoidosis Adenocarcinoma gastric Adenomatous polyposis coli Streptococcal infection Partial lipodystrophy Colorectal cancer stage III Post procedural oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    ๐Ÿ‡ช๐Ÿ‡บ Europe
    ๐Ÿ‡ฆ๐Ÿ‡น Austria
    ๐Ÿ‡ญ๐Ÿ‡ท Croatia
    ๐Ÿ‡จ๐Ÿ‡ฟ Czech Republic
    ๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
    ๐Ÿ‡ช๐Ÿ‡ช Estonia
    ๐Ÿ‡ซ๐Ÿ‡ฎ Finland
    ๐Ÿ‡ซ๐Ÿ‡ท France
    ๐Ÿ‡ฉ๐Ÿ‡ช Germany
    ๐Ÿ‡ฎ๐Ÿ‡ธ Iceland
    ๐Ÿ‡ฎ๐Ÿ‡น Italy
    ๐Ÿ‡ฑ๐Ÿ‡ป Latvia
    ๐Ÿ‡ฑ๐Ÿ‡น Lithuania
    ๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
    ๐Ÿ‡ณ๐Ÿ‡ด Norway
    ๐Ÿ‡ต๐Ÿ‡ฑ Poland
    ๐Ÿ‡ต๐Ÿ‡น Portugal
    ๐Ÿ‡ท๐Ÿ‡ด Romania
    ๐Ÿ‡ธ๐Ÿ‡ฐ Slovakia
    ๐Ÿ‡ธ๐Ÿ‡ฎ Slovenia
    ๐Ÿ‡ช๐Ÿ‡ธ Spain
    ๐Ÿ‡ธ๐Ÿ‡ช Sweden

Cerebral haemorrhage

  • A study to evaluate the use of diroximel fumarate to reduce brain swelling in patients with a stroke caused by bleeding in the brain.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Diroximel Fumarate
    France

  • Study of clopidogrel and acetylsalicylic acid (aspirin) for prevention of cardiovascular events in patients who survived intracerebral hemorrhage stroke

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    Belgium The Netherlands

  • Study on Esketamine Hydrochloride and Sodium Chloride for Patients with Severe Acute Brain Injury

    Recruiting

    3 1 1
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Sodium Chloride
    Denmark

  • Study on the Effects of Continuing or Stopping Simvastatin and Atorvastatin in Patients with Spontaneous Lobar Intracerebral Hemorrhage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Simvastatin
    • Atorvastatin
    Spain

  • Study on Naloxegol to Prevent Constipation in Patients with Brain Injury and Opioid Use

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    • Gastrointestinal motility disorder
    • Head injury
    Investigated Drugs:
    • Naloxegol Oxalate
    France

  • Study on Avoiding Anticoagulation with Apixaban for Patients with Intracerebral Hemorrhage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Apixaban
    France
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

ยฉ 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidล‚owy!
Numer nieprawidล‚owy!